Premium
Splicing analysis of rare/novel synonymous or intronic variants identified in ABCB11 heterozygotes presenting as progressive intrahepatic cholestasis with low γ‐glutamyltransferase
Author(s) -
Wang NengLi,
Qiu YiLing,
Guan WenCai,
Li Gang,
Lu Yi,
Zhang MeiHong,
Luan WeiSha,
Wang JianShe
Publication year - 2018
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/hepr.13055
Subject(s) - minigene , biology , rna splicing , intron , exon , in silico , genetics , microbiology and biotechnology , gene , alternative splicing , rna
Aim The aim of this study was to analyze the pathogenicity of rare/novel synonymous or intronic variants identified in ABCB11 heterozygotes presenting as progressive intrahepatic cholestasis with low γ‐glutamyltransferase. Methods The enrolled variants were identified in ABCB11 between October 2009 and June 2016. The effects on pre‐RNA splicing were analyzed by in silico tools and minigene splicing assay. Results There were three intronic (c.908 + 5G > A, c.2815‐8A > G, and c.612‐15_‐6del10bp) and two synonymous (c.1809G > A, p.K603 K and c.2418C > T, p.G806G) variants with unknown significance identified in ABCB11 of five ABCB11 heterozygotes. Parental studies were carried out for four patients, and revealed that the variants with unknown significance were compound heterozygous with other pathogenic variants. The five variants with unknown significance had minor allele frequency <0.1% or were absent from controls, and had positive prediction results by in silico tools. The effects on pre‐RNA splicing were further confirmed by minigene splicing assay. c.908 + 5A caused abnormal splicing in at least 78.5 ± 3.8% of products using a cryptic splice site (ss) 22 nucleotides (nt) upstream of the wild‐type (WT) 5′ss. Seven nucleotides of intron 22 upstream of the WT 3'ss was retained for all products from c.2815‐8G. c.612‐15_‐6del caused exon 8 skipping in 24.8 ± 7.7% of products, and 55 nt of exon 8 downstream of the WT 3′ss removal in remaining products. c.1809A led to exon 15 skipping. c.2418 T removed exon 20 and 62 nt of exon 21 downstream of the WT 3′ss by using a cryptic ss. Conclusions We successfully identified five pathogenic synonymous or intronic variants with some common features. These features might help to choose the right variant for further functional assay.